MD Anderson is the greatest cancer center in the galaxy.
At least according to George Norcross III, chairman of the board of Cooper Health System, it is. He told New Jersey Gov. Chris Christie as much when the two were discussing a new partnership to bring MD Anderson’s signature, multidisciplinary care to the Garden State.
While MD Anderson can’t substantiate these cosmic claims, it’s arguably a global leader in cancer research and treatment, with a mission to influence care across the United States and around the world.
“Cancer is an enemy that respects no border, no geography, no age and no gender,” says MD Anderson President Ronald DePinho, M.D.
MD Anderson Cancer Center at Cooper opened in Camden, N.J., on Oct. 7, 2013, as the newest partner member in the MD Anderson Cancer Network™. Partner members are co-branded clinical extensions of MD Anderson that bring the institution’s knowledge and expertise to their communities. The network, which was created in 2012, includes 12 members — two partner members and 10 certified members — in nine states.
Through its expansive — and strategically growing — network, the institution has a presence on almost every continent. MD Anderson has locations in Spain and Turkey, and consults with health care providers around the world, from China to Brazil, where it's helping South America’s leading hospital develop a comprehensive cancer center.
In addition to these clinical relationships, global academic collaborations are facilitated through the Sister Institution Network, a group of 27 leading research and medical institutions in 20 countries working collaboratively to reduce the world’s cancer burden.
While there’s only one MD Anderson, its global network ensures that millions of people have access to the distinctive care that has made it the most respected cancer center in the world — and some say, the galaxy.